| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | -100.0% |
| R&D Expense | $13.9M | +24.6% |
| SG&A Expense | $14.0M | -20.2% |
| Operating Income | -$27.9M | +1.6% |
| Income Tax | $0 | — |
| Net Income | -$29.1M | -1.6% |
| EPS (Basic) | -$1.39 | +16.3% |
| EPS (Diluted) | -$1.39 | +16.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $17.4M | -27.6% |
| Short-term Investments | $0 | — |
| Current Assets | $18.2M | -26.9% |
| Total Assets | $19.5M | -26.7% |
| Current Liabilities | $22.4M | +63.6% |
| Stockholders' Equity | -$7.2M | -161.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$26.2M | -16.3% |
| Capital Expenditures | $17K | -64.6% |
| Investing Cash Flow | -$17K | -100.4% |
| Financing Cash Flow | $19.7M | +86.4% |
| Free Cash Flow | -$26.3M | -16.1% |